| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2017 | 2016 | 2014 | 2013 | 2012 | 2010 | 2009 | 2009 | 2008 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46,1 k € | -97.3% | 1,7 M € | -37.7% | 2,8 M € | -93.2% | 41,0 M € | -14.9% | 48,2 M € | +22.6% | 39,3 M € | -11.9% | 44,6 M € | +4.6% | 42,6 M € | +12.0% | 38,1 M € | +4.3% | 36,5 M € | +1.7% | 35,9 M € | +7.2% | 33,4 M € | +39.6% | 24,0 M € | -21.7% | 30,6 M € | +11.3% | 27,5 M € | |
| EBITDA | 15,2 k € | +102.9% | -517,4 k € | -251.2% | -147,3 k € | -140.7% | 361,5 k € | +314.3% | -168,7 k € | -107.2% | 2,3 M € | +119.8% | 1,1 M € | -23.2% | 1,4 M € | -4.3% | 1,4 M € | +94.3% | 742,7 k € | -24.6% | 984,7 k € | -22.2% | 1,3 M € | +19.3% | 1,1 M € | -37.5% | 1,7 M € | -20.2% | 2,1 M € | |
| Operating profit | -87,5 k € | +79.2% | -420,2 k € | -74.9% | -240,2 k € | +94.6% | -4,4 M € | -487.3% | -750,9 k € | -136.2% | 2,1 M € | +133.3% | 888,8 k € | +10.6% | 803,5 k € | +33.7% | 601,2 k € | -20.7% | 758,5 k € | +16.2% | 652,6 k € | -21.7% | 833,6 k € | +10.3% | 755,7 k € | -37.9% | 1,2 M € | +42.0% | 856,8 k € | |
| Profit/loss | -95,1 k € | +78.7% | -446,5 k € | -174.6% | -162,6 k € | +96.5% | -4,7 M € | -356.8% | -1,0 M € | -181.4% | 1,3 M € | +237.4% | 375,0 k € | -9.2% | 412,9 k € | +29.8% | 318,1 k € | -6.1% | 338,8 k € | -16.2% | 404,5 k € | -14.3% | 471,7 k € | -16.8% | 566,9 k € | -55.0% | 1,3 M € | +361.1% | 273,0 k € | |
| Equity | -232,8 k € | -69.0% | -137,8 k € | -144.6% | 308,7 k € | -91.6% | 3,7 M € | -56.0% | 8,4 M € | -10.9% | 9,4 M € | +36.7% | 6,9 M € | +5.7% | 6,5 M € | +16.7% | 5,6 M € | +146.1% | 2,3 M € | +17.5% | 1,9 M € | +22.0% | 1,6 M € | +42.4% | 1,1 M € | +104.0% | 545,4 k € | +121.7% | -2,5 M € | |
| Total assets | 267,4 k € | -79.2% | 1,3 M € | -43.3% | 2,3 M € | -89.2% | 21,0 M € | -19.6% | 26,1 M € | +9.3% | 23,9 M € | +9.3% | 21,9 M € | -1.8% | 22,3 M € | -2.5% | 22,8 M € | +9.5% | 20,9 M € | +6.9% | 19,5 M € | -1.3% | 19,8 M € | +16.6% | 17,0 M € | +6.2% | 16,0 M € | +1.8% | 15,7 M € | |
| Cash | 67,6 k € | -56.8% | 156,3 k € | +146.0% | 63,5 k € | -95.8% | 1,5 M € | +3344.2% | 43,5 k € | +2009.3% | 2,1 k € | -99.4% | 330,2 k € | -74.3% | 1,3 M € | -14.3% | 1,5 M € | +16.7% | 1,3 M € | -17.9% | 1,6 M € | +236.5% | 465,3 k € | +19.2% | 390,2 k € | +8.6% | 359,2 k € | -37.2% | 571,9 k € | |
| Debts | 403,6 k € | -71.7% | 1,4 M € | -27.3% | 2,0 M € | -87.8% | 16,1 M € | -9.0% | 17,7 M € | +24.1% | 14,3 M € | -1.9% | 14,5 M € | -3.0% | 15,0 M € | -10.7% | 16,8 M € | -8.4% | 18,3 M € | +6.8% | 17,2 M € | +0.8% | 17,0 M € | +16.0% | 14,7 M € | +1.9% | 14,4 M € | -15.3% | 17,0 M € | |
| Staff | 12,1 | 14,5 | 45,5 | 85,8 | 88,5 | 90,7 | 96,5 | 99,3 | 92,7 | 93,5 | 93,9 | 98 | 94 | 94,1 | 89,7 | |||||||||||||||
Public limited company · Mechelen · incorporated on 01/01/1968 · 12,1 ETP
Public limited company loss-making in the latest fiscal year. Cash position declining (-56.8%).
Solid counterparty for a standard engagement.
ORTHOSPINE is a Public limited company incorporated in 1968. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Mechelen. It employs on average 12,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette